PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Rare Diseases Giessen (ZSEGI), University Hospital Giessen, Giessen, Germany.\', \'Division of Metabolism, Bambino Gesù Children\'s Hospital, IRCCS, Rome, Italy.\', \'MetabERN, Regional Coordinating Center for Rare Diseases, Udine University Hospital, Udine, Italy.\', \'Krabbe UK, London, UK.\', \'MSD Action Foundation, Dublin, Ireland.\', \'Portuguese Association for CDG and Other Rare Metabolic Diseases (APCDG-DMR), Almada, Portugal.\', \'Italian Association of Patients With Alkaptonuria (aimAKU), Siena, Italy.\', \'MetabERN, Regional Coordinating Center for Rare Diseases, Udine University Hospital, Udine, Italy. maurizio.scarpa@metab.ern-net.eu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13023-020-01619-x
?:doi
?:hasPublicationType
?:journal
  • Orphanet journal of rare diseases
is ?:pmid of
?:pmid
?:pmid
  • 33272301
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.413
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33272301>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33272301>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all